SCHEMBL31465704

SCHEMBL31465704

CCOC(=O)C(=O)c1c(C)cc(OC)cc1C

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.61
HPGD P15428 2/20 0.61
KMT2A Q03164 3/20 0.43
POLB P06746 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
PKM P14618 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7523545 0.83 ALDH1A1 (0.46) CYP3A4HPGDKMT2ASMN1; SMN2ALDH1A1
Phosphine SCHEMBL27473852 0.81 ALDH1A1 (0.45) CYP3A4HPGDKMT2ASMN1; SMN2ALDH1A1
SCHEMBL5514458 0.81 SMN1; SMN2 (0.57) CYP3A4HPGDKMT2APOLBSMN1; SMN2
SCHEMBL31465700 0.77 CYP3A4 (0.55) CYP3A4HPGDKMT2APOLBSMN1; SMN2
Ethyl Everninate SCHEMBL1640418 0.76 CYP3A4 (1.00) CYP3A4HPGDKMT2APOLBSMN1; SMN2
Ethyl Everninate SCHEMBL31233848 0.76 CYP3A4 (1.00) CYP3A4HPGDKMT2APOLBSMN1; SMN2
SCHEMBL4106403 0.76 CYP3A4 (0.71) CYP3A4HPGDKMT2APOLBSMN1; SMN2
SCHEMBL10362928 0.76 HPGD (0.71) CYP3A4HPGDKMT2APOLBSMN1; SMN2
SCHEMBL31465673 0.76 CA12 (0.50) CYP3A4KMT2AALDH1A1L3MBTL1HTT
SCHEMBL9720612 0.76 CYP3A4 (0.57) CYP3A4HPGDKMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025056724-A1 IMINOAMIDE-TYPE COMPOUNDS AS LIGANDS FOR COPPER-CATALYZED COUPLING REACTIONS OF (HETERO)ARYL HALIDES BAYER AKTIENGESELLSCHAFT (DE) 2025-03-20 WO disclosed